MSCMX
Price
$15.08
Change
-$0.93 (-5.81%)
Updated
Dec 18 closing price
RGEBX
Price
$71.86
Change
-$9.28 (-11.44%)
Updated
Dec 18 closing price
Ad is loading...

MSCMX vs RGEBX

Header iconMSCMX vs RGEBX Comparison
Open Charts MSCMX vs RGEBXBanner chart's image
Morgan Stanley Insight C
Price$15.08
Change-$0.93 (-5.81%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$71.86
Change-$9.28 (-11.44%)
VolumeN/A
CapitalizationN/A
MSCMX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSCMX vs. RGEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCMX is a StrongBuy and RGEBX is a Buy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 313B vs. MSCMX (1.61B). RGEBX pays higher dividends than MSCMX: RGEBX (0.16) vs MSCMX (0.00). MSCMX was incepted earlier than RGEBX: MSCMX (10 years) vs RGEBX (10 years). MSCMX is a more actively managed with annual turnover of: 40.00 vs. RGEBX (31.00). RGEBX has a lower initial minimum investment than MSCMX: RGEBX (250) vs MSCMX (1000). MSCMX annual gain was more profitable for investors over the last year : 60.23 vs. RGEBX (18.29). RGEBX return over 5 years is better than : 43.83 vs. MSCMX (-40.50).
MSCMXRGEBXMSCMX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years10 years-
Gain YTD60.07518.074332%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B313B1%
Annual Yield % from dividends0.000.16-
Returns for 1 year60.2318.29329%
Returns for 3 years-57.813.53-1,635%
Returns for 5 years-40.5043.83-92%
Returns for 10 yearsN/A68.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTV3.06N/A
N/A
Innovid Corp
OPCH23.42-0.04
-0.17%
Option Care Health
AON358.88-2.87
-0.79%
Aon plc
LMAT90.93-1.17
-1.27%
LeMaitre Vascular
ITRM1.83-0.04
-2.14%
Iterum Therapeutics plc